glp-1 drug Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care America's Poison Centers - GLP-1
Description
Uzman Gr Do
The evidence is early but promising, and these products represent the mildest possible alternative to pharmaceutical GLP-1 agonists
Buenaventura T
[DOI] [PubMed] [Google Scholar] Wise LA, Rothman KJ, Mikkelsen EM, Srensen HT, Riis A, Hatch EE
